The new guidelines, published in European Heart Journal and presented at ESC Congress 2026, represent a major overhaul ...
A HEAL-CHF trial found 90% of heart failure patients showed improved cardiac function after receiving lab-grown heart muscle cell injections.
Few syndromes are as common, morbid, or unevenly managed as heart failure (HF), and its burden continues to grow worldwide.
ScienceAlert on MSN
Cardiologists just changed the universal definition of heart failure
(Mohammed Haneefa Nizamudeen/iStock/Getty Images Plus) Leading cardiology organizations around the world are having a change ...
Reflecting improved understanding and treatment advances, new European Society of Cardiology (ESC) Guidelines on heart ...
Millions of Americans live with a hidden heart condition, and researchers have found a key, noticeable warning sign.
Results from two Phase 2 clinical trials assessing tovinontrine in both major types of chronic heart failure will be presented at the Heart Failure Society of America annual scientific ...
Artificial intelligence (AI) can rapidly screen patients for clinical trial enrollment, according to a study published in JAMA and led by Mass General Brigham researchers. Their novel AI-assisted ...
[1] Henry T, et al. GenePHIT Phase 2 baseline characteristics: a double blind, placebo-controlled trial to assess safety and efficacy of AB-1002 gene therapy in heart failure with reduced ejection ...
Chinese stem cell therapy reverses heart failure in 90% of patients, landmark trial finds - Patients who received treatment ...
Interviews with patients hospitalized for heart failure, caregivers, providers and organizational leaders highlighted several ...
Interesting Engineering on MSN
90% of heart failure patients improved after the largest stem cell trial to date
Nine out of every ten patients in a Chinese heart failure trial showed significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results